Targeted Therapies in Oncology - Image 1

£56.99

CRC Press Targeted Therapies in Oncology

Name: Targeted Therapies in Oncology
Brand: CRC Press
Price: 56.99 GBP
Availability: InStock

General Medical Issues

Same price for 6 weeks. Today is much like next week.

£57 for 41 days straight · last change was Jan 2026

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 446 days • 446 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 446 days • 9 price levels

Days at Price

Current Price

Price Analysis

Most common price: £57 (228 days, 51.1%)

Price range: £20 - £59

Price levels: 9 different prices over 446 days

Description

Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and proliferation. Targeted Therapies in Oncology, Second Edition provides a concise timely panorama of existing targeted therapies and progress into future anticancer treatments. These therapies notably include: Targeted agents of immune checkpoints Signal-transduction inhibitors Antiangiogenic agents Vascular-disrupting agents Apoptosis modulators Stem cell inhibitors Tumor profiling for drug development The book emphasizes the biology behind this new class of drugs as well as the clinical achievements obtained. The contributors to this volume stand at the cutting edge of cancer research and treatment around the world. About the Author Giuseppe Giaccone is a professor and associate director of the Lombardi Cancer Center at Georgetown University in Washington, D.C. He was previously the head of the Department of Medical Oncology, Free University Medical Center, Amsterdam, the Netherlands, and most recently the chief of the Medical Oncology Branch of the National Cancer Institute in Bethesda. Professor Giaccone has written more than 500 peer-reviewed scientific papers and several books and book chapters and is a board member of several international scientific journals. His fields of research include lung cancer and the development of novel anticancer agents. He was the chair of the Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer until 2000. He has organized a number of international conferences, such as the Topoisomerase Symposia and the Targeted Anticancer Therapy conferences. Jean-Charles Soria is a professor of medicine at South-Paris University, France, and adjunct professor at the University of Texas MD Anderson Cancer Center. He is the chairman of the Early Drug Development Department at Gustave-Roussy, Villejuif, France. He is also a member of the Thoracic Multidisciplinary Committee at this institute. Professor Soria has authored over 300 peer-reviewed scientific papers, including publications as first or last author in the New England Journal of Medicine, the Journal of the National Cancer Institute, the Journal of Clinical Oncology, Clinical Cancer Research, and Annals of Oncology. He is a board member of several international scientific journals. His main research interests include early clinical development across solid tumors, pharmacodynamic biomarkers, lung cancer, and personalized medicine. He is also involved in translational research related to precision medicine and tumor progression, notably in lung cancer models (INSERM unit 981).

Product Specifications

Brand: CRC Press
Format: paperback
ASIN: 0367379368
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 23 October 2019
Listed Since: 25 June 2019

Barcode

No barcode data available

CRC Press Targeted Therapies in Oncology

Same price for 6 weeks. Today is much like next week.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Biophotonics, Tryptophan and Disease

Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)

Cancer Biology

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Withrow and MacEwen's Small Animal Clinical Oncology

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Hsp90 in Cancer: Beyond the Usual Suspects (Volume 129) (Advances in Cancer Research, Volume 129)

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation, 64)

Impact of Energy Balance on Cancer Disparities: 9

The Practitioner′s Handbook: A Guide for Counsellors, Psychotherapists and Counselling Psychologists

Cancer Cell Signaling: Targeting Signaling Pathways Toward Therapeutic Approaches to Cancer

Advances in Clinical Science: 878 (Advances in Experimental Medicine and Biology, 878)

Encyclopedia of Cancer and Society

Environmental Factors, Genes, and the Development of Human Cancers

All That Matters - Olympian Memoir, Sunday Times Bestseller

Advances in Respiratory Cancerogenesis: 911 (Advances in Experimental Medicine and Biology, 911)

Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics

Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery

Health and Medicine: 1279 (Advances in Experimental Medicine and Biology, 1279)

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)